nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—ADRBK1—blood plasma—acquired immunodeficiency syndrome	0.0146	0.0495	CbGeAlD
Isoprenaline—MAPK1—blood plasma—acquired immunodeficiency syndrome	0.0144	0.0488	CbGeAlD
Isoprenaline—PIK3R2—digestive system—acquired immunodeficiency syndrome	0.014	0.0475	CbGeAlD
Isoprenaline—PIK3R1—retina—acquired immunodeficiency syndrome	0.0116	0.0392	CbGeAlD
Isoprenaline—PIK3R2—nervous system—acquired immunodeficiency syndrome	0.0108	0.0367	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—acquired immunodeficiency syndrome	0.0104	0.0354	CbGeAlD
Isoprenaline—PIK3R3—vagina—acquired immunodeficiency syndrome	0.0084	0.0285	CbGeAlD
Isoprenaline—PIK3R2—brain—acquired immunodeficiency syndrome	0.00829	0.0281	CbGeAlD
Isoprenaline—PIK3R3—lung—acquired immunodeficiency syndrome	0.00794	0.0269	CbGeAlD
Isoprenaline—PIK3R1—blood—acquired immunodeficiency syndrome	0.00774	0.0262	CbGeAlD
Isoprenaline—PIK3R1—bone marrow—acquired immunodeficiency syndrome	0.00749	0.0254	CbGeAlD
Isoprenaline—PIK3R1—spinal cord—acquired immunodeficiency syndrome	0.00746	0.0253	CbGeAlD
Isoprenaline—PIK3R3—nervous system—acquired immunodeficiency syndrome	0.00736	0.0249	CbGeAlD
Isoprenaline—PIK3R1—vagina—acquired immunodeficiency syndrome	0.00718	0.0243	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—acquired immunodeficiency syndrome	0.00708	0.024	CbGeAlD
Isoprenaline—MAPK1—skin of body—acquired immunodeficiency syndrome	0.00693	0.0235	CbGeAlD
Isoprenaline—PIK3R1—lung—acquired immunodeficiency syndrome	0.00679	0.023	CbGeAlD
Isoprenaline—Pallor—Delavirdine—acquired immunodeficiency syndrome	0.00572	0.022	CcSEcCtD
Isoprenaline—ADRBK1—lymphoid tissue—acquired immunodeficiency syndrome	0.00569	0.0193	CbGeAlD
Isoprenaline—PIK3R3—brain—acquired immunodeficiency syndrome	0.00562	0.0191	CbGeAlD
Isoprenaline—ADRBK1—digestive system—acquired immunodeficiency syndrome	0.00562	0.0191	CbGeAlD
Isoprenaline—MAPK1—lymphoid tissue—acquired immunodeficiency syndrome	0.00561	0.019	CbGeAlD
Isoprenaline—MAPK1—digestive system—acquired immunodeficiency syndrome	0.00554	0.0188	CbGeAlD
Isoprenaline—PIK3R3—lymph node—acquired immunodeficiency syndrome	0.00543	0.0184	CbGeAlD
Isoprenaline—ADRBK1—blood—acquired immunodeficiency syndrome	0.00536	0.0182	CbGeAlD
Isoprenaline—MAPK1—blood—acquired immunodeficiency syndrome	0.00528	0.0179	CbGeAlD
Isoprenaline—ADRBK1—bone marrow—acquired immunodeficiency syndrome	0.00518	0.0176	CbGeAlD
Isoprenaline—MAPK1—bone marrow—acquired immunodeficiency syndrome	0.00511	0.0173	CbGeAlD
Isoprenaline—MAPK1—spinal cord—acquired immunodeficiency syndrome	0.00509	0.0172	CbGeAlD
Isoprenaline—ADRBK1—vagina—acquired immunodeficiency syndrome	0.00496	0.0168	CbGeAlD
Isoprenaline—MAPK1—vagina—acquired immunodeficiency syndrome	0.00489	0.0166	CbGeAlD
Isoprenaline—PIK3R1—brain—acquired immunodeficiency syndrome	0.0048	0.0163	CbGeAlD
Isoprenaline—ADRBK1—lung—acquired immunodeficiency syndrome	0.0047	0.0159	CbGeAlD
Isoprenaline—PIK3R1—lymph node—acquired immunodeficiency syndrome	0.00464	0.0157	CbGeAlD
Isoprenaline—MAPK1—lung—acquired immunodeficiency syndrome	0.00463	0.0157	CbGeAlD
Isoprenaline—ADRBK1—nervous system—acquired immunodeficiency syndrome	0.00435	0.0147	CbGeAlD
Isoprenaline—MAPK1—nervous system—acquired immunodeficiency syndrome	0.00429	0.0145	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—acquired immunodeficiency syndrome	0.00419	0.0142	CbGeAlD
Isoprenaline—MAPK1—central nervous system—acquired immunodeficiency syndrome	0.00413	0.014	CbGeAlD
Isoprenaline—Bronchospasm—Nelfinavir—acquired immunodeficiency syndrome	0.00402	0.0155	CcSEcCtD
Isoprenaline—Sweating—Nelfinavir—acquired immunodeficiency syndrome	0.00349	0.0134	CcSEcCtD
Isoprenaline—Sweating—Stavudine—acquired immunodeficiency syndrome	0.00348	0.0134	CcSEcCtD
Isoprenaline—Tremor—Amprenavir—acquired immunodeficiency syndrome	0.00336	0.0129	CcSEcCtD
Isoprenaline—ADRBK1—brain—acquired immunodeficiency syndrome	0.00332	0.0113	CbGeAlD
Isoprenaline—MAPK1—brain—acquired immunodeficiency syndrome	0.00328	0.0111	CbGeAlD
Isoprenaline—ADRBK1—lymph node—acquired immunodeficiency syndrome	0.00321	0.0109	CbGeAlD
Isoprenaline—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.00321	0.0123	CcSEcCtD
Isoprenaline—MAPK1—lymph node—acquired immunodeficiency syndrome	0.00316	0.0107	CbGeAlD
Isoprenaline—Sweating—Zidovudine—acquired immunodeficiency syndrome	0.00302	0.0116	CcSEcCtD
Isoprenaline—Sweating—Indinavir—acquired immunodeficiency syndrome	0.00281	0.0108	CcSEcCtD
Isoprenaline—Sweating—Efavirenz—acquired immunodeficiency syndrome	0.00266	0.0102	CcSEcCtD
Isoprenaline—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00251	0.00966	CcSEcCtD
Isoprenaline—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.00247	0.00948	CcSEcCtD
Isoprenaline—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00244	0.0094	CcSEcCtD
Isoprenaline—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.00242	0.00931	CcSEcCtD
Isoprenaline—Tension—Zidovudine—acquired immunodeficiency syndrome	0.00242	0.00931	CcSEcCtD
Isoprenaline—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.00239	0.00921	CcSEcCtD
Isoprenaline—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.00235	0.00905	CcSEcCtD
Isoprenaline—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.00231	0.00889	CcSEcCtD
Isoprenaline—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00231	0.00888	CcSEcCtD
Isoprenaline—Tension—Indinavir—acquired immunodeficiency syndrome	0.00225	0.00866	CcSEcCtD
Isoprenaline—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00224	0.00864	CcSEcCtD
Isoprenaline—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00224	0.00861	CcSEcCtD
Isoprenaline—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.00223	0.00857	CcSEcCtD
Isoprenaline—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00222	0.00855	CcSEcCtD
Isoprenaline—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00221	0.00852	CcSEcCtD
Isoprenaline—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00216	0.00831	CcSEcCtD
Isoprenaline—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.00216	0.00831	CcSEcCtD
Isoprenaline—Tremor—Indinavir—acquired immunodeficiency syndrome	0.00215	0.00826	CcSEcCtD
Isoprenaline—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00214	0.00822	CcSEcCtD
Isoprenaline—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00213	0.0082	CcSEcCtD
Isoprenaline—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00213	0.00818	CcSEcCtD
Isoprenaline—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.0021	0.00809	CcSEcCtD
Isoprenaline—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.0021	0.00808	CcSEcCtD
Isoprenaline—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.0021	0.00807	CcSEcCtD
Isoprenaline—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00209	0.00805	CcSEcCtD
Isoprenaline—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00207	0.00796	CcSEcCtD
Isoprenaline—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00206	0.00793	CcSEcCtD
Isoprenaline—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00206	0.00792	CcSEcCtD
Isoprenaline—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00204	0.00786	CcSEcCtD
Isoprenaline—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00204	0.00785	CcSEcCtD
Isoprenaline—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00782	CcSEcCtD
Isoprenaline—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00203	0.00782	CcSEcCtD
Isoprenaline—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00203	0.00781	CcSEcCtD
Isoprenaline—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00203	0.00779	CcSEcCtD
Isoprenaline—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00201	0.00774	CcSEcCtD
Isoprenaline—ADRB1—lung—acquired immunodeficiency syndrome	0.00196	0.00666	CbGeAlD
Isoprenaline—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00195	0.00751	CcSEcCtD
Isoprenaline—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00195	0.00749	CcSEcCtD
Isoprenaline—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00195	0.00748	CcSEcCtD
Isoprenaline—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00194	0.00747	CcSEcCtD
Isoprenaline—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00191	0.00736	CcSEcCtD
Isoprenaline—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00191	0.00736	CcSEcCtD
Isoprenaline—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.0019	0.00643	CbGeAlD
Isoprenaline—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00188	0.00724	CcSEcCtD
Isoprenaline—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00188	0.00722	CcSEcCtD
Isoprenaline—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00719	CcSEcCtD
Isoprenaline—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00716	CcSEcCtD
Isoprenaline—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00186	0.00716	CcSEcCtD
Isoprenaline—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00183	0.00705	CcSEcCtD
Isoprenaline—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00183	0.00705	CcSEcCtD
Isoprenaline—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00182	0.007	CcSEcCtD
Isoprenaline—ADRB1—nervous system—acquired immunodeficiency syndrome	0.00182	0.00616	CbGeAlD
Isoprenaline—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00181	0.00696	CcSEcCtD
Isoprenaline—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00181	0.00695	CcSEcCtD
Isoprenaline—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.0018	0.00691	CcSEcCtD
Isoprenaline—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.0069	CcSEcCtD
Isoprenaline—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.00688	CcSEcCtD
Isoprenaline—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.00175	0.00594	CbGeAlD
Isoprenaline—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00174	0.00668	CcSEcCtD
Isoprenaline—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00173	0.00665	CcSEcCtD
Isoprenaline—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00173	0.00664	CcSEcCtD
Isoprenaline—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00664	CcSEcCtD
Isoprenaline—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.00662	CcSEcCtD
Isoprenaline—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00172	0.00662	CcSEcCtD
Isoprenaline—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00171	0.00658	CcSEcCtD
Isoprenaline—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00171	0.00657	CcSEcCtD
Isoprenaline—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00169	0.00652	CcSEcCtD
Isoprenaline—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00169	0.00651	CcSEcCtD
Isoprenaline—Headache—Didanosine—acquired immunodeficiency syndrome	0.00167	0.00643	CcSEcCtD
Isoprenaline—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00167	0.00642	CcSEcCtD
Isoprenaline—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00167	0.00641	CcSEcCtD
Isoprenaline—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00166	0.00639	CcSEcCtD
Isoprenaline—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.00639	CcSEcCtD
Isoprenaline—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00638	CcSEcCtD
Isoprenaline—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.00637	CcSEcCtD
Isoprenaline—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00635	CcSEcCtD
Isoprenaline—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00165	0.00634	CcSEcCtD
Isoprenaline—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00164	0.00629	CcSEcCtD
Isoprenaline—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00164	0.00629	CcSEcCtD
Isoprenaline—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.00615	CcSEcCtD
Isoprenaline—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.00615	CcSEcCtD
Isoprenaline—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00613	CcSEcCtD
Isoprenaline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00158	0.00609	CcSEcCtD
Isoprenaline—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00608	CcSEcCtD
Isoprenaline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00158	0.00608	CcSEcCtD
Isoprenaline—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00158	0.00606	CcSEcCtD
Isoprenaline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00591	CcSEcCtD
Isoprenaline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00153	0.00589	CcSEcCtD
Isoprenaline—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00153	0.00589	CcSEcCtD
Isoprenaline—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00587	CcSEcCtD
Isoprenaline—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00587	CcSEcCtD
Isoprenaline—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.00152	0.00514	CbGeAlD
Isoprenaline—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00151	0.00582	CcSEcCtD
Isoprenaline—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00151	0.0058	CcSEcCtD
Isoprenaline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00151	0.0058	CcSEcCtD
Isoprenaline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0015	0.00578	CcSEcCtD
Isoprenaline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.00562	CcSEcCtD
Isoprenaline—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.0056	CcSEcCtD
Isoprenaline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00145	0.0056	CcSEcCtD
Isoprenaline—Headache—Stavudine—acquired immunodeficiency syndrome	0.00145	0.00558	CcSEcCtD
Isoprenaline—CYP1A1—blood—acquired immunodeficiency syndrome	0.00145	0.0049	CbGeAlD
Isoprenaline—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00144	0.00555	CcSEcCtD
Isoprenaline—Headache—Abacavir—acquired immunodeficiency syndrome	0.00143	0.0055	CcSEcCtD
Isoprenaline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00142	0.00548	CcSEcCtD
Isoprenaline—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00544	CcSEcCtD
Isoprenaline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00541	CcSEcCtD
Isoprenaline—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00536	CcSEcCtD
Isoprenaline—ADRB1—brain—acquired immunodeficiency syndrome	0.00139	0.00471	CbGeAlD
Isoprenaline—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00534	CcSEcCtD
Isoprenaline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00531	CcSEcCtD
Isoprenaline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00138	0.00529	CcSEcCtD
Isoprenaline—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00524	CcSEcCtD
Isoprenaline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00135	0.00521	CcSEcCtD
Isoprenaline—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00134	0.00516	CcSEcCtD
Isoprenaline—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00516	CcSEcCtD
Isoprenaline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00516	CcSEcCtD
Isoprenaline—CYP1A1—vagina—acquired immunodeficiency syndrome	0.00134	0.00454	CbGeAlD
Isoprenaline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00512	CcSEcCtD
Isoprenaline—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.005	CcSEcCtD
Isoprenaline—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00128	0.00493	CcSEcCtD
Isoprenaline—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00127	0.00488	CcSEcCtD
Isoprenaline—CYP1A1—lung—acquired immunodeficiency syndrome	0.00127	0.00429	CbGeAlD
Isoprenaline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00126	0.00485	CcSEcCtD
Isoprenaline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00476	CcSEcCtD
Isoprenaline—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00467	CcSEcCtD
Isoprenaline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.0046	CcSEcCtD
Isoprenaline—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.00117	0.00398	CbGeAlD
Isoprenaline—Headache—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00451	CcSEcCtD
Isoprenaline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.0045	CcSEcCtD
Isoprenaline—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.00113	0.00383	CbGeAlD
Isoprenaline—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00432	CcSEcCtD
Isoprenaline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.0043	CcSEcCtD
Isoprenaline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00428	CcSEcCtD
Isoprenaline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00426	CcSEcCtD
Isoprenaline—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00416	CcSEcCtD
Isoprenaline—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00408	CcSEcCtD
Isoprenaline—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00404	CcSEcCtD
Isoprenaline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00398	CcSEcCtD
Isoprenaline—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00396	CcSEcCtD
Isoprenaline—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.001	0.00387	CcSEcCtD
Isoprenaline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000996	0.00383	CcSEcCtD
Isoprenaline—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00098	0.00377	CcSEcCtD
Isoprenaline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00095	0.00365	CcSEcCtD
Isoprenaline—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000943	0.00363	CcSEcCtD
Isoprenaline—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000929	0.00357	CcSEcCtD
Isoprenaline—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0009	0.00346	CcSEcCtD
Isoprenaline—CYP1A1—brain—acquired immunodeficiency syndrome	0.000897	0.00304	CbGeAlD
Isoprenaline—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000894	0.00344	CcSEcCtD
Isoprenaline—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000866	0.00294	CbGeAlD
Isoprenaline—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000853	0.00328	CcSEcCtD
Isoprenaline—ADRBK1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000166	0.000372	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000166	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000166	0.000372	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000164	0.000369	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000164	0.000369	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000163	0.000367	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000163	0.000366	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000162	0.000364	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00016	0.00036	CbGpPWpGaD
Isoprenaline—PIK3R1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00016	0.00036	CbGpPWpGaD
Isoprenaline—PIK3R2—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.00016	0.00036	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000159	0.000358	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000159	0.000358	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000159	0.000358	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000157	0.000353	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000155	0.000348	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000154	0.000347	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000154	0.000347	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000154	0.000347	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000154	0.000346	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000153	0.000344	CbGpPWpGaD
Isoprenaline—MAPK1—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	0.000153	0.000343	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000153	0.000343	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000152	0.000342	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000152	0.000342	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000152	0.000342	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000151	0.00034	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000151	0.000339	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00015	0.000338	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.00015	0.000337	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000149	0.000335	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000149	0.000334	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000148	0.000333	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000148	0.000332	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000147	0.00033	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000146	0.000328	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000146	0.000327	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000145	0.000326	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000145	0.000326	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000144	0.000323	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000144	0.000323	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000143	0.000321	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000143	0.000321	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CCR5—acquired immunodeficiency syndrome	0.000142	0.000319	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CCR5—acquired immunodeficiency syndrome	0.00014	0.000314	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000139	0.000311	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000138	0.000311	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000138	0.00031	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000138	0.000309	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000137	0.000309	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000137	0.000308	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000137	0.000307	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000136	0.000307	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000136	0.000307	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000136	0.000306	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000136	0.000306	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000136	0.000305	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000136	0.000305	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000135	0.000304	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000135	0.000304	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000135	0.000304	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000135	0.000304	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000135	0.000303	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000134	0.000302	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000134	0.000302	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000133	0.000299	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000133	0.000298	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000132	0.000297	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CCR2—acquired immunodeficiency syndrome	0.000132	0.000296	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000131	0.000295	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00013	0.000291	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00013	0.000291	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.00013	0.000291	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000129	0.00029	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000127	0.000286	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000127	0.000286	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000127	0.000286	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000127	0.000286	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000127	0.000285	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000127	0.000285	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000127	0.000285	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000127	0.000285	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000126	0.000284	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000126	0.000283	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IFNG—acquired immunodeficiency syndrome	0.000126	0.000282	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000125	0.000281	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000125	0.000281	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000125	0.00028	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000124	0.000279	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000124	0.000279	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000124	0.000279	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000123	0.000276	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—IL6—acquired immunodeficiency syndrome	0.000122	0.000275	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000122	0.000274	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000122	0.000274	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD4—acquired immunodeficiency syndrome	0.000121	0.000272	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00012	0.00027	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000118	0.000266	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000118	0.000264	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000118	0.000264	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000117	0.000264	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000115	0.000259	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000115	0.000259	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000115	0.000259	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CCR5—acquired immunodeficiency syndrome	0.000115	0.000259	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD79A—acquired immunodeficiency syndrome	0.000115	0.000258	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000115	0.000258	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000115	0.000258	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000115	0.000258	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000114	0.000257	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000113	0.000254	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000113	0.000254	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000113	0.000253	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—IL6—acquired immunodeficiency syndrome	0.000113	0.000253	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—CD4—acquired immunodeficiency syndrome	0.000112	0.000251	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL2—acquired immunodeficiency syndrome	0.000112	0.000251	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00011	0.000248	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000109	0.000245	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000109	0.000244	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000109	0.000244	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000107	0.000241	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000107	0.000241	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000106	0.000239	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000106	0.000237	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000103	0.000231	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000101	0.000228	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IFNG—acquired immunodeficiency syndrome	0.0001	0.000225	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.95e-05	0.000224	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IFNG—acquired immunodeficiency syndrome	9.85e-05	0.000221	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.8e-05	0.00022	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.73e-05	0.000219	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD4—acquired immunodeficiency syndrome	9.66e-05	0.000217	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.66e-05	0.000217	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.58e-05	0.000215	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD4—acquired immunodeficiency syndrome	9.52e-05	0.000214	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.52e-05	0.000214	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.45e-05	0.000212	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.4e-05	0.000211	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD40LG—acquired immunodeficiency syndrome	9.37e-05	0.000211	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—IL2—acquired immunodeficiency syndrome	9.34e-05	0.00021	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.31e-05	0.000209	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.27e-05	0.000208	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CSF2—acquired immunodeficiency syndrome	9.27e-05	0.000208	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD8A—acquired immunodeficiency syndrome	9.27e-05	0.000208	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	9.24e-05	0.000208	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CD4—acquired immunodeficiency syndrome	9.14e-05	0.000205	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—IL6—acquired immunodeficiency syndrome	8.97e-05	0.000202	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.95e-05	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CD4—acquired immunodeficiency syndrome	8.92e-05	0.0002	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-B—acquired immunodeficiency syndrome	8.91e-05	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL2—acquired immunodeficiency syndrome	8.89e-05	0.0002	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—IL6—acquired immunodeficiency syndrome	8.84e-05	0.000199	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.81e-05	0.000198	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	8.81e-05	0.000198	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CD4—acquired immunodeficiency syndrome	8.79e-05	0.000197	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.77e-05	0.000197	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL2—acquired immunodeficiency syndrome	8.76e-05	0.000197	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.73e-05	0.000196	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.7e-05	0.000196	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.68e-05	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	8.66e-05	0.000195	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.64e-05	0.000194	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.6e-05	0.000193	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.58e-05	0.000193	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.51e-05	0.000191	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.5e-05	0.000191	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—ALB—acquired immunodeficiency syndrome	8.48e-05	0.000191	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.47e-05	0.00019	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.45e-05	0.00019	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IFNG—acquired immunodeficiency syndrome	8.11e-05	0.000182	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.06e-05	0.000181	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.01e-05	0.00018	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.99e-05	0.00018	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.99e-05	0.00018	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.9e-05	0.000178	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.88e-05	0.000177	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.87e-05	0.000177	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—IL6—acquired immunodeficiency syndrome	7.84e-05	0.000176	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.84e-05	0.000176	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD4—acquired immunodeficiency syndrome	7.83e-05	0.000176	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CCR5—acquired immunodeficiency syndrome	7.82e-05	0.000176	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.73e-05	0.000174	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.69e-05	0.000173	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.27e-05	0.000163	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.25e-05	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD4—acquired immunodeficiency syndrome	7.23e-05	0.000162	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.21e-05	0.000162	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL2—acquired immunodeficiency syndrome	7.2e-05	0.000162	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.17e-05	0.000161	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.09e-05	0.000159	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—acquired immunodeficiency syndrome	6.93e-05	0.000156	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ALB—acquired immunodeficiency syndrome	6.87e-05	0.000154	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.81e-05	0.000153	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.81e-05	0.000153	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.66e-05	0.00015	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.66e-05	0.00015	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—acquired immunodeficiency syndrome	6.56e-05	0.000147	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.08e-05	0.000137	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—acquired immunodeficiency syndrome	6.05e-05	0.000136	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.99e-05	0.000135	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.82e-05	0.000131	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.75e-05	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.72e-05	0.000129	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.66e-05	0.000127	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.63e-05	0.000127	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—acquired immunodeficiency syndrome	5.59e-05	0.000126	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—acquired immunodeficiency syndrome	5.51e-05	0.000124	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.48e-05	0.000123	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.36e-05	0.00012	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—acquired immunodeficiency syndrome	5.32e-05	0.00012	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—acquired immunodeficiency syndrome	5.23e-05	0.000117	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.18e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—acquired immunodeficiency syndrome	5.15e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.11e-05	0.000115	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.07e-05	0.000114	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.03e-05	0.000113	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.99e-05	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—acquired immunodeficiency syndrome	4.94e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.92e-05	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—acquired immunodeficiency syndrome	4.91e-05	0.00011	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL2—acquired immunodeficiency syndrome	4.9e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—acquired immunodeficiency syndrome	4.82e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—acquired immunodeficiency syndrome	4.75e-05	0.000107	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.67e-05	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.66e-05	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.63e-05	0.000104	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.57e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.57e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.55e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.52e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.47e-05	0.0001	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.24e-05	9.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—acquired immunodeficiency syndrome	4.23e-05	9.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—acquired immunodeficiency syndrome	3.91e-05	8.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.38e-05	7.59e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.33e-05	7.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.17e-05	7.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.15e-05	7.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—acquired immunodeficiency syndrome	2.88e-05	6.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.74e-05	6.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.7e-05	6.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.68e-05	6.03e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.67e-05	6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—acquired immunodeficiency syndrome	2.66e-05	5.97e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.64e-05	5.93e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.63e-05	5.9e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	2.59e-05	5.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.86e-05	4.18e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.59e-05	3.56e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.55e-05	3.49e-05	CbGpPWpGaD
